Investor Relations

Corporate Profile

NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or FIND-IO, platform, NextCure studies various immune cells to discover and understand targets and structural components of immune cells and their impact on immune function in order to develop immunomedicines. NextCure is focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

Stock Quote




Data Provided by Refinitiv. Minimum 15 minutes delayed.